| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |